# Marc Lémann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-lemann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,329 |
| Field | Inflammatory Bowel Disease |
| h-index | 71 |
| i10-index | 144 |
| Last Known Institution | Délégation Paris 7 |
| OpenAlex ID | https://openalex.org/A5034194110 |
| Works | 267 |

## Researcher papers

- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of-2/)
- [Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47](https://scholariq.org/papers/meta-analysis-identifies-29-additional-ulcerative-colitis-risk-loci-increasing/)
- [Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study](https://scholariq.org/papers/lymphoproliferative-disorders-in-patients-receiving-thiopurines-for-inflammatory/)
- [Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial](https://scholariq.org/papers/ciclosporin-versus-infliximab-in-patients-with-severe-ulcerative-colitis/)
- [Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped](https://scholariq.org/papers/maintenance-of-remission-among-patients-with-crohn-s-disease-on-antimetabolite/)
- [Development of the Crohnʼs disease digestive damage score, the Lémann score](https://scholariq.org/papers/development-of-the-crohn-s-disease-digestive-damage-score-the-lemann-score/)
- [Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine](https://scholariq.org/papers/long-term-follow-up-of-patients-with-crohn-s-disease-treated-with-azathioprine/)
- [Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial](https://scholariq.org/papers/ineffectiveness-of-i-lactobacillus-johnsonii-i-la1-for-prophylaxis-of/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)

## Researcher university

- [Délégation Paris 7](https://scholariq.org/institutions/delegation-paris-7/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.